Google DeepMind launched AlphaGenome, an AI tool that helps identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different cells and tissues.
AlphaGenome can analyse up to one million DNA letters at once.
Researchers trained it on large public human and mouse genetics databases.
Scientists expect it to accelerate research into cancer, heart disease, and autoimmune disorders.
Experts say the tool could guide new drug development and future gene therapies.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in Chicago, USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He graduated with a degree in Journalism from the University of Florida. Over the years, he has contributed to leading outlets such as The New York Times, CNN, and Reuters. Recognized for his sharp reporting and thoughtful analysis, Andrew delivers accurate and timely news that keeps readers updated on key national and global developments.
Add A Comment